2018
DOI: 10.1039/c8lc00408k
|View full text |Cite
|
Sign up to set email alerts
|

Microfabricated devices for oral drug delivery

Abstract: Oral administration of drugs is most convenient for patients and therefore the ultimate goal when developing new medication. The physical barriers in the body, low pH of the stomach and degradation by enzymes in the gastrointestinal tract are a few of the obstacles to succeeding with oral drug delivery. Microfabricated devices show promise to overcome some of these hindrances and thereby improve the bioavailability of drugs after oral administration. There is an increasing focus on microfabricated oral drug de… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
53
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
9
1

Relationship

6
4

Authors

Journals

citations
Cited by 62 publications
(54 citation statements)
references
References 65 publications
1
53
0
Order By: Relevance
“…These devices have been tested in a Caco2 monolayer but are still under improvements and considerations for the intestinal conditions. Further details about similar devices can be found in Chirra and Desai (2012), Fox et al (2014Fox et al ( , 2015, and Nielsen et al (2018).…”
Section: Intestinal Patchesmentioning
confidence: 99%
“…These devices have been tested in a Caco2 monolayer but are still under improvements and considerations for the intestinal conditions. Further details about similar devices can be found in Chirra and Desai (2012), Fox et al (2014Fox et al ( , 2015, and Nielsen et al (2018).…”
Section: Intestinal Patchesmentioning
confidence: 99%
“…Oral drug delivery remains the preferred administration route due to ease of use, flexibility and patient compliance [1]. Despite many advances in oral delivery systems [2][3][4], the design of 'the ideal delivery device' is still widely discussed and depends on the application.…”
Section: Introductionmentioning
confidence: 99%
“…Hence, high dose and dosing frequency of eye drops is prescribed to compensate for the low bioavailability, but it causes the side effects and reduces patient compliance [7,8]. To address these drawbacks, therapeutic contact lenses have been proposed for ocular drug delivery, due to their unique properties such as extended wear, high corneal bioavailability (more than 50%) and long drug residence time (over 30 min) in comparison to the eye drop therapy [9][10][11][12][13][14]. The current researches mainly focused on passive drug delivery through sustained diffusion, which still has long release duration and reduced patient compliance.…”
Section: Introductionmentioning
confidence: 99%